JP Morgan Raises PT On Alkermes To $21

Loading...
Loading...
JP Morgan has raised the price target on Alkermes
ALKS
from $16 to $21 and maintains its Overweight rating.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetAnalyst RatingsalkermesBiotechnologyHealth CareJP Morgan
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...